Latin America Needle-Free Injectors Market Outlook (2022-2033)

The Latin America Needle-free Injectors Market size is expected to reach US$ 1,061.6 million by 2033 from US$ 675.2 million in 2025. The market is estimated to record a CAGR of 5.8 % from 2026 to 2033.

Report Coverage
  • Product: Liquid Jet Injectors, Powder Jet Injectors, Spring-Powered / Gas-Powered Injectors, Other products
  • Usability: Disposable, Reusable
  • Application: Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, Other Applications
US$ 675.2 Mn Market size in 2025
US$ 1,061.6 Mn Market Size by 2033
5.8% CAGR, 2026 - 2033
2026-2033 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Latin America Needle-Free Injectors Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Latin America Needle-Free Injectors Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Latin America Needle-Free Injectors Market Regional Analysis

6.2 Latin America Needle-Free Injectors Market Revenue 2022-2033 (US$ Million)
6.3 Latin America Needle-Free Injectors Market Forecast Analysis

7. Latin America Needle-Free Injectors Market Analysis – by Product

7.1 Liquid Jet Injectors
  • 7.1.1 Overview
  • 7.1.2 Liquid Jet Injectors: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.2 Powder Jet Injectors
  • 7.2.1 Overview
  • 7.2.2 Powder Jet Injectors: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.3 Spring-Powered / Gas-Powered Injectors
  • 7.3.1 Overview
  • 7.3.2 Spring-Powered / Gas-Powered Injectors: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.4 Other products
  • 7.4.1 Overview
  • 7.4.2 Other products: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)

8. Latin America Needle-Free Injectors Market Analysis – by Usability

8.1 Disposable
  • 8.1.1 Overview
  • 8.1.2 Disposable: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.2 Reusable
  • 8.2.1 Overview
  • 8.2.2 Reusable: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)

9. Latin America Needle-Free Injectors Market Analysis – by Application

9.1 Cancer
  • 9.1.1 Overview
  • 9.1.2 Cancer: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.2 Autoimmune Disorders
  • 9.2.1 Overview
  • 9.2.2 Autoimmune Disorders: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.3 Hormonal Disorders
  • 9.3.1 Overview
  • 9.3.2 Hormonal Disorders: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.4 Pain Management
  • 9.4.1 Overview
  • 9.4.2 Pain Management: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Other Applications: Latin America Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)

10. Latin America Needle-Free Injectors Market – Latin America Analysis

10.1 Overview

10.2 Latin America
  • 10.2.1 Latin America Needle-Free Injectors Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.2.1.1 Latin America Needle-Free Injectors Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Mexico: Latin America Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.1.1 Mexico: Latin America Needle-Free Injectors Market Breakdown, by Product
    • 10.2.1.1.2 Mexico: Latin America Needle-Free Injectors Market Breakdown, by Usability
    • 10.2.1.1.3 Mexico: Latin America Needle-Free Injectors Market Breakdown, by Application
  • 10.2.1.2 Brazil: Latin America Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.2.1 Brazil: Latin America Needle-Free Injectors Market Breakdown, by Product
    • 10.2.1.2.2 Brazil: Latin America Needle-Free Injectors Market Breakdown, by Usability
    • 10.2.1.2.3 Brazil: Latin America Needle-Free Injectors Market Breakdown, by Application
  • 10.2.1.3 Argentina: Latin America Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.3.1 Argentina: Latin America Needle-Free Injectors Market Breakdown, by Product
    • 10.2.1.3.2 Argentina: Latin America Needle-Free Injectors Market Breakdown, by Usability
    • 10.2.1.3.3 Argentina: Latin America Needle-Free Injectors Market Breakdown, by Application
  • 10.2.1.4 Peru: Latin America Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.4.1 Peru: Latin America Needle-Free Injectors Market Breakdown, by Product
    • 10.2.1.4.2 Peru: Latin America Needle-Free Injectors Market Breakdown, by Usability
    • 10.2.1.4.3 Peru: Latin America Needle-Free Injectors Market Breakdown, by Application
  • 10.2.1.5 Chile: Latin America Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.5.1 Chile: Latin America Needle-Free Injectors Market Breakdown, by Product
    • 10.2.1.5.2 Chile: Latin America Needle-Free Injectors Market Breakdown, by Usability
    • 10.2.1.5.3 Chile: Latin America Needle-Free Injectors Market Breakdown, by Application
  • 10.2.1.6 Colombia: Latin America Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.6.1 Colombia: Latin America Needle-Free Injectors Market Breakdown, by Product
    • 10.2.1.6.2 Colombia: Latin America Needle-Free Injectors Market Breakdown, by Usability
    • 10.2.1.6.3 Colombia: Latin America Needle-Free Injectors Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Gerresheimer AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Becton Dickinson and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Owen Mumford Ltd.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 West Pharmaceutical Services
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 SHL Medical
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 YPSOMED
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Phillips-Medisize
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Nemera
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 SMC Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Haselmeier GmbH
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full L Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Access the full L Market Report
145 pages PDF & Excel | 2026-05-20